Neuphoria Therapeutics (NEUP) Treasury Shares (2025)
Neuphoria Therapeutics (NEUP) reported Treasury Shares of $33915.0 for Q3 2025, little changed on a QoQ basis from $33915.0 in Q2 2025.
Neuphoria Therapeutics (NEUP) has 1 years of Treasury Shares data on file, last reported at $33915.0 in Q3 2025.
- Quarterly Treasury Shares changed N/A year-over-year to $33915.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $33915.0 (changed N/A YoY) and the FY2025 annual result came in at $33915.0, changed N/A from the prior year.
- Treasury Shares held at $33915.0 in Q3 2025 per NEUP's latest filing, from $33915.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $33915.0 in Q2 2025 and bottomed at $33915.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Neuphoria Therapeutics | 28.35 Mn | 8.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 33,915.00 |
| Sep 30, 2025 | 33,915.00 |
| Jun 30, 2025 | 33,915.00 |
| Jun 30, 2025 | 33,915.00 |